The efficacy and safety of dual-pathway inhibition therapy among patients with peripheral artery disease: A meta-analysis

被引：0
|
作者：
Villanueva, P. [1 ]
机构：
[1] Philippine Gen Hosp, Manila, Philippines
来源：
VASCULAR MEDICINE | 2021年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
1223
引用
下载
收藏
页码：NP5 / NP5
页数：1
相关论文
共 50 条
  • [1] The efficacy and safety of dual-pathway inhibition therapy among patients with peripheral arterial disease - a meta-analysis
    Mapili, J.
    Davin, A. S.
    Villanueva, L. M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2024 - 2024
  • [2] Efficacy and safety of dual-pathway inhibition in patients with cardiovascular disease: a meta-analysis of 49 802 patients from 7 randomized trials
    Galli, Mattia
    Capodanno, Davide
    Benenati, Stefano
    D'Amario, Domenico
    Crea, Filippo
    Andreotti, Felicita
    Angiolillo, Dominick J.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (05) : 519 - 528
  • [3] Efficacy and Safety of Rivaroxaban Therapy for Patients With Peripheral Artery Disease: A Systematic Review and Meta-Analysis
    Hao, Yujun
    Han, Weitao
    Mou, Detang
    Wang, Jintao
    VASCULAR AND ENDOVASCULAR SURGERY, 2021, 55 (07) : 712 - 720
  • [4] Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysis
    Sibbing, Dirk
    Blaha, Michael J.
    Chawla, Rajinder
    Lavalle-Cobo, Augusto
    Kishore, Amit
    Lanas, Angel
    Li, Li
    Santilli, Francesca
    Schnell, Oliver
    Shi, Zhongwei
    EUROPEAN CARDIOLOGY REVIEW, 2024, 19
  • [5] ELIGIBILITY TO DUAL PATHWAY INHIBITION THERAPY IN PATIENTS WITH CORONARY OR PERIPHERAL ARTERY DISEASE
    Greco, Antonio
    Laudani, Claudio
    Cavallo, Matteo
    Vannuzzi, Fabio
    Giaquinta, Alessia
    Capranzano, Piera
    Calvi, Valeria
    Isola, Gaetano
    Pedulla, Eugenio
    Pasquale, Rocco De
    Uva, Maurizio Giacinto
    Di Cataldo, Antonio
    Veroux, Pierfrancesco
    Tamburino, Corrado
    Capodanno, Davide
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [6] Meta-Analysis of Efficacy and Safety of Proton Pump Inhibitors with Dual Antiplatelet Therapy for Coronary Artery Disease
    Khan, Safi U.
    Lone, Ahmad N.
    Asad, Zain Ul Abideen
    Rahman, Hammad
    Khan, Muhammad Shahzeb
    Saleem, Muhammad A.
    Arshad, Adeel
    Nawaz, Najma
    Sattur, Sudhakar
    Kaluski, Edo
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2019, 20 (12) : 1125 - 1133
  • [7] Meta-Analysis of Safety and Efficacy of Proton Pump Inhibitors with Dual Antiplatelet Therapy for Coronary Artery Disease
    Khan, Safi
    Asad, Zain
    Lone, Ahmad
    Rahman, Hammad
    Sattur, Sudhakar
    Kaluski, Edo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B325 - B325
  • [8] Efficacy of Cilostazol After Endovascular Therapy for Peripheral Artery Disease: A Meta-Analysis
    Saballo, Darlene Pearl
    Yumena, Marc Jusenn
    Gonzales, Lea Arceli
    CIRCULATION, 2022, 146
  • [9] A Systematic Review and Meta-Analysis of Efficacy and Safety of Cilostazol Prescription in Patients With Femoropopliteal Peripheral Artery Disease After Endovascular Therapy
    Tan, Qiang
    Chen, Zhilong
    Wu, Huaping
    Wang, Haifei
    Chen, Jingquan
    Lai, Kun
    Zhang, Fuzhao
    Kang, Tengyao
    Zheng, Jianghua
    JOURNAL OF ENDOVASCULAR THERAPY, 2024,
  • [10] Safety and efficacy of EFGR and VEGF signaling pathway inhibition therapy in patients with colorectal cancer: a meta-analysis
    Siwen Liu
    Rong Ma
    Haixia Cao
    Shaorong Yu
    Dan Chen
    Changwen Jing
    Zhuo Wang
    Junying Zhang
    Jifeng Feng
    Jianzhong Wu
    Oncology and Translational Medicine, 2019, 5 (02) : 80 - 90
12345